Drug Safety Triager vs. OpenEvidence
A side-by-side comparison based on G2 review data.
| Metric | Drug Safety Triager | OpenEvidence |
|---|---|---|
| Overall rating | 4.5 | 4.4 |
| Review count | 15 | 37 |
| Ease of use | 9.1 | 9.3 |
| Ease of setup | 9.3 | 9.1 |
| Quality of support | 8.6 | 8.9 |
| Meets requirements | 9.0 | 8.9 |
| NPS | 73.333333 | 64.864865 |
| Small Business | 33.3% | 51.4% |
| Mid-Market | 40.0% | 29.7% |
| Enterprise | 26.7% | 18.9% |
| Total page views | 16 | 621 |
| Total LLM citations | 5 | 5,516 |
Drug Safety Triager
Drug Safety Triager is our GxP validated and audit-ready pharmacovigilance (PV) literature review software solution, created from the ground up to monitor literature for Individual Case Safety Reporting, Aggregate Reports and Signal detection. It makes the drug safety literature monitoring process more efficient, cost-effective and compliant. Using intelligent automation from our machine learning engine DELVE (part of the Dialog platform) and integration with upstream and downstream processes, Drug Safety Triager takes literature reviewing to a new level.
OpenEvidence
OpenEvidence is a medical information platform designed to assist healthcare professionals in navigating the vast and rapidly expanding body of medical research. Originating from the Mayo Clinic Platform Accelerate program, it integrates multimedia and clinical findings from esteemed sources like The New England Journal of Medicine. By aggregating, synthesizing, and presenting clinically relevant evidence in accessible formats, OpenEvidence empowers medical practitioners to make informed, evidence-based decisions, ultimately enhancing patient outcomes.